PDF(Pubmed)
Abstract：
BACKGROUND: While the guidelines acknowledge the anticipated benefits of using an implantable cardioverter defibrillator (ICD) in individuals with catecholaminergic polymorphic ventricular tachycardia (CPVT). However, the potential adverse effects have received less attention.
METHODS: To address this issue comprehensively, we will explore various databases such as the Cochrane Library, Web of Science, EMBASE and PubMed. Our study will include CPVT patients, both with and without ICD implantation. Two researchers will evaluate the eligible studies independently and gather pertinent data. The quality of the studies included will be assessed using either the Newcastle-Ottawa Scale or the Cochrane Risk of Bias Tool. Data analysis will be conducted using RevMan.
BACKGROUND: Because this research depends exclusively on existing studies, obtaining patient informed consent and ethics approval is unnecessary. The results of this meta-analysis will be shared at conferences or in peer-reviewed journals.
UNASSIGNED: CRD42022370824.
METHODS: To address this issue comprehensively, we will explore various databases such as the Cochrane Library, Web of Science, EMBASE and PubMed. Our study will include CPVT patients, both with and without ICD implantation. Two researchers will evaluate the eligible studies independently and gather pertinent data. The quality of the studies included will be assessed using either the Newcastle-Ottawa Scale or the Cochrane Risk of Bias Tool. Data analysis will be conducted using RevMan.
BACKGROUND: Because this research depends exclusively on existing studies, obtaining patient informed consent and ethics approval is unnecessary. The results of this meta-analysis will be shared at conferences or in peer-reviewed journals.
UNASSIGNED: CRD42022370824.
摘要：
背景：虽然指南承认在儿茶酚胺能多形性室性心动过速（CPVT）患者中使用植入式心律转复除颤器（ICD）的预期益处。然而,潜在的不良影响受到的关注较少。
方法：为了全面解决这个问题，我们将探索各种数据库，如Cochrane图书馆，WebofScience,EMBASE和PubMed。我们的研究将包括CPVT患者，有和没有ICD植入。两名研究人员将独立评估符合条件的研究并收集相关数据。纳入研究的质量将使用纽卡斯尔-渥太华量表或Cochrane偏差风险工具进行评估。数据分析将使用RevMan进行。
背景：因为这项研究完全依赖于现有的研究，获得患者知情同意和伦理批准是不必要的.这项荟萃分析的结果将在会议或同行评审的期刊上分享。
■CRD4202237824。
方法：为了全面解决这个问题，我们将探索各种数据库，如Cochrane图书馆，WebofScience,EMBASE和PubMed。我们的研究将包括CPVT患者，有和没有ICD植入。两名研究人员将独立评估符合条件的研究并收集相关数据。纳入研究的质量将使用纽卡斯尔-渥太华量表或Cochrane偏差风险工具进行评估。数据分析将使用RevMan进行。
背景：因为这项研究完全依赖于现有的研究，获得患者知情同意和伦理批准是不必要的.这项荟萃分析的结果将在会议或同行评审的期刊上分享。
■CRD4202237824。
